| Literature DB >> 36131179 |
Despina A Gkika1, Athanasios C Mitropoulos1, Dimitra A Lambropoulou2, Ioannis K Kalavrouziotis3, George Z Kyzas4.
Abstract
Over the past three decades, environmental concerns about the water pollution have been raised on societal and industrial levels. The presence of pollutants stemming from cosmetic products has been documented in wastewater streams outflowing from industrial as well as wastewater treatment plants. To this end, a series of consistent measures should be taken to prevent emerging contaminants of water resources. This need has driven the development of technologies, in an attempt to mitigate their impact on the environment. This work offers a thorough review of existing knowledge on cosmetic wastewater treatment approaches, including, coagulation, dissolved air flotation, adsorption, activated sludge, biodegradation, constructed wetlands, and advanced oxidation processes. Various studies have already documented the appearance of cosmetics in samples retrieved from wastewater treatment plants (WWTPs), which have definitely promoted our comprehension of the path of cosmetics within the treatment cycle; however, there are still multiple blanks to our knowledge. All treatments have, without exception, their own limitations, not only cost-wise, but also in terms of being feasible, effective, practical, reliable, and environmentally friendly.Entities:
Keywords: Biological methods; Chemical methods; Cosmetics; Green technologies; Physical methods; Wastewater treatment technologies
Mesh:
Substances:
Year: 2022 PMID: 36131179 PMCID: PMC9553780 DOI: 10.1007/s11356-022-23045-1
Source DB: PubMed Journal: Environ Sci Pollut Res Int ISSN: 0944-1344 Impact factor: 5.190
Fig. 1Treatment technologies of wastewaters discharged from cosmetic industries
List of cosmetics identified
| Category | Group | Subgroups | Compound | Chemical name | CAS number |
|---|---|---|---|---|---|
| Cosmetics | Pharmaceutical contaminants | Estrogens and hormones | Estradiol | (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | 50–28-2 |
| Pharmaceutical contaminants | Estrogens and hormones | Ethinylestradiol | (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol | 57–63-6 | |
| Pharmaceutical contaminants | Estrogens and hormones | Estriol | (8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol | 50–27-1 | |
| Pharmaceutical contaminants | NSAIDS | Diclofenac | 2-[2-(2,6-dichloroanilino)phenyl]acetic acid | 15,307–86-5 | |
| Pharmaceutical contaminants | NSAIDS | Ibuprofen | 2-[4-(2-methylpropyl)phenyl]propanoic acid | 15,687–27-1 | |
| Pharmaceutical contaminants | Alkylphenols | Bisphenol A | 2,2-Bis(4-hydroxyphenyl)propane | 80–05-7 | |
| Pharmaceutical contaminants | NSAIDS | Cholesterol | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 57–88-5 | |
| Cosmetic ingredients | (UV) filter | Ultraviolet (UV) filter benzophenone-3 (BP-3) | 2-hydroxy-4-methoxybenzophenone | 131–57-7 | |
| Cosmetic ingredients | (UV) filter | Benzophenone | Benzophenone/diphenylmethanone | 119–61-9 | |
| Cosmetic and pharmaceutical preservatives | Parabens | Methylparaben (MP) | Methyl 4-hydroxybenzoate | 99–76-3 | |
| Cosmetic and pharmaceutical preservatives | Parabens | Ethylparaben (EP) | Ethyl 4-hydroxybenzoate | 120–47-8 | |
| Cosmetic and pharmaceutical preservatives | Parabens | propylparaben (PP) | Propyl 4-hydroxybenzoate | 94–13-3 | |
| Cosmetic and pharmaceutical preservatives | Parabens | Butylparaben (BP) | Butyl 4-hydroxybenzoate | 94–26-8 | |
| PPCPs | Corrosion inhibitors | Benzotriazole, 1,2,3-benzotriazole itself (BTri) | 2H-benzotriazole | 95–14-7 | |
| PPCPs | Corrosion inhibitors | Benzothiazole-2-sulfonate (BTSA) | Benzothiazole-2-sulfonic acid | 941–57-1 |
Advantages and limitations of the physical treatment options
| Treatment technology | Advantages | Limitations |
|---|---|---|
| Adsorption | Technologically simple (simple equipment) and easy to accommodate for multiple formats Targets multiple pollutants Very efficient process with fast kinetics Outstanding quality of the treated effluent (Crini and Lichtfouse Activated carbon treatments are deemed as financially viable options and are already used in some treatment facilities (Hadla et al. | The adsorption effectiveness relies on the types of the contaminants, the properties of the adsorbent, as well as other environmental circumstances (Luo et al. Destruction of the adsorbent (might need to be incinerated, regenerated or replaced) Regeneration is costly and leads to loss of material (Crini and Lichtfouse |
| Coagulation and flocculation | Simple process Integrated physicochemical process A variety of chemicals is already commercially produced Low capital requirements Acceptable sludge settling and dewatering results Notable decrease in the chemical and biochemical oxygen demands (Crini and Lichtfouse | Adjunction of non-reusable materials necessary Requires the monitoring of the PH levels of the effluent Results in higher sludge amounts, which require management, treatment, and further expenses Ineffective in the extraction of arsenic (Crini and Lichtfouse |
| Dissolved air flotation | The solid design, brief retention time, high hydraulic loads, and small size of flocculation and flotation chambers, which allow for low capital costs (Rybachuk and Jodłowski | There are concerns regarding the mechanism of bubble/particle (aggregates) interactions besides the adhesion via hydrophobic forces (Rubio et al. |
Fig. 2Elimination rate of 9 evaluated micropollutants from spiked wastewater after 5 min, 2 h, and 48 h BCDP treatment (Fenyvesi et al. 2020)
Fig. 3The flocculation mechanism of cationic polyacrylamide (Tang et al. 2020)
Removal of cosmetics from wastewaters by physical methods categorized according to their mechanism
| Compound | Material | Initial concentration | Removal (%, time) | Mechanism | Ref |
|---|---|---|---|---|---|
| Turbidity (TUR), suspended solids, (SS), and chemical oxygen demand (COD) | Cactus tree, species Aluminum sulfate (AS) as coagulant and fresh cladodes juice (FCJ) as bioflocculant | 0.5 g/L AS 5 mL FCJ | TUR 93.65%, SS 82.75% COD and 64.30% after 30 min | Coagulation flocculation and sedimentation | (Rachdi et al. |
| 4‑nitrophenol | rGO/Ag2O nanocomposite | 3 mL of 0.1 mM 4-NP solution | 97% after 35 min | Adsorption | (Iqbal et al. |
| Estradiol, ethinyl estradiol, estriol, diclofenac, ibuprofen, bisphenol A, and cholesterol | Cyclodextrin bead polymer | 1 kg activated BCDP treated 300 L of effluent. Poured through columns with 40.8 L volume | Between 85 and 99% depending on the compound, after 5 min | Adsorption | (Fenyvesi et al. |
Chemical oxygen demand (COD), Total suspended solids (TSS) | A1 6010 | 1 mL/L | COD 78.8%, TSS 95.2% After 10 min | Coagulation and Dissolved air flotation | (Wiliński et al. |
Chemical oxygen demand (COD), Total suspended solids (TSS) | A1 6010 | 1 mL/L | COD 79.1%, TSS 94.4% After 10 min | Coagulation and Dissolved ozone flotation | (Wiliński et al. |
Chemical oxygen demand (COD), Total suspended solids (TSS), Various micropollutants | A1 3010 | 1 mL/L | COD 81.3%, TSS 96.3%, VMP 93.8% After 10 min | Coagulation and Dissolved air flotation | (Wiliński et al. |
Chemical oxygen demand (COD), Total suspended solids (TSS), Various micropollutants | A1 3010 | 1 mL/L | COD 81.1%, TSS 96.3%, VMP 96.3% After 10 min | Coagulation and Dissolved ozone flotation | (Wiliński et al. |
Sample 5, Chemical oxygen demand (COD) | Al2(SO4)3 | 125 mg/L | COD 68% after 2 min | Dissolved air flotation | (Bogacki et al. |
Sample 5, Chemical oxygen demand (COD) | Al 3010 Al | 1 mg/L | COD 68% after 2 min | Dissolved air flotation | (Bogacki et al. |
Sample 5, Chemical oxygen demand (COD) | Al 3010 Al | 1 mg/L | COD 77% after 2 min | Dissolved air flotation | (Bogacki et al. |
Sample 3, Chemical oxygen demand (COD) | Al2(SO4)3 | 125 mg/L | COD 77.1% after 2 min | Dissolved air flotation | (Bogacki et al. |
Sample 3, Chemical oxygen demand (COD) | Al 3010 Al | 0.5 mg/L | COD 72.9% after 2 min | Dissolved air flotation | (Bogacki et al. |
Sample 3, Chemical oxygen demand (COD) | Al 3010 Al | 0.5 mg/L | COD 75.6% after 2 min | Dissolved air flotation | (Bogacki et al. |
Advantages and limitations of the biological treatment technologies
| Treatment technology | Advantages | Limitations |
|---|---|---|
| Aerobic-anaerobic | Increased purification levels, ability to manage high organic loads, generation of limited amounts of sludges that are often quite stable, and production of methane as end-product (Aziz and Abu Amr | Anaerobic treatment requires time (Samer |
| Activated sludge | Inexpensive (Onesios et al. | Incomplete degradation leading to the creation of toxic degradation by-products Non-effective in the removal of recalcitrant contaminants (Oulton et al. Depends on energy (Sharma and Sanghi Low availability or lack of degraders (Wang and Wang |
| Biodegradation | Prime method for the elimination of PPCPs (Wang and Wang | |
| Constructed wetlands | Low energy requirements Low operational cost (Kaur et al. | Large area footprint Required operating cost (Kaur et al. |
| Membrane bioreactor process | Applicable versus many contaminants (Weiss and Reemtsma | Inability to remove recalcitrant contaminants (Kaur et al. |
Fig. 4Structure of the microbial community (a) and abundance of polyphosphate and glycogen accumulating organisms (PAOs and GAOs) (b) in the AS of the SBR (Muszyński et al. 2019)
Fig. 5The reactions taking place during photocatalytic oxidation and reduction (Awfa et al. 2018)
Removal of cosmetics by biological methods
| Compound | Material | Initial concentration | Removal (%, time) | Mechanism | Ref |
|---|---|---|---|---|---|
| Ultraviolet (UV) filter benzophenone-3 (BP-3) in oxic and anoxic conditions (nitrate, sulfate, and Fe [III]-reducing) | 10% activated sludge | 1 mg/L | 84.7–94.1% after 42 days | Aerobic and anaerobic processes | Liu et al. ( |
| DOC | MBR -sludge | 5 g/L | 79% after 4 w | Membrane bioreactor process | Weiss and Reemtsma ( |
| BTri | MBR-sludge | 5 g/L | 61% after 4 w | Membrane bioreactor process | Weiss and Reemtsma ( |
| 5-TTri | MBR-sludge | 5 g/L | 61% after 4 w | Membrane bioreactor process | Weiss and Reemtsma ( |
| BTSA | MBR-sludge | 5 g/L | 65 ± 16% after 4 w | Membrane bioreactor process | Weiss and Reemtsma ( |
| 2-NSA | MBR-sludge | 5 g/L | 94 ± 4% after 4 w | Membrane bioreactor process | Weiss and Reemtsma ( |
| 1-NSA | MBR-sludge | 5 g/L | 92 ± 4% after 4 w | Membrane bioreactor process | Weiss and Reemtsma ( |
| Benzophenone-3 (BP-3) | 5 mg/L | 65% after 8 d | Biodegradation | Jin et al. ( | |
| Biocides, steroid hormones, antibiotics, PPCPs | Tidal flow constructed wetlands (TFCWs) with baffle | - | B 92.4%, SH 99.5% A 77.2%, PPCPs 92.9% after 24 h | Constructed wetlands | Cheng et al. ( |
| Biocides, steroid hormones, antibiotics, PPCPs | Tidal flow constructed wetlands (TFCWs) with plants | - | B 93.4%, SH 98.5% A 85.2%, PPCPs 94.3% after 24 h | Constructed wetlands | Cheng et al. ( |
| Biocides, steroid hormones, antibiotics, PPCPs | Tidal flow constructed wetlands (TFCWs) with both baffle and plants | - | B 97.1%, SH 99.8% A 90.2%, PPCPs 97.4% after 24 h | Constructed wetlands | Cheng et al. ( |
Advantages and limitations of chemical methods
| Treatment technology | Advantage | Limitations |
|---|---|---|
| Fenton | The on-site creation of H2O2, which can bypass the risks linked to its transportation, storage, and management; The continuous regeneration of Fe2+, which can hinder the iron sludge generation and enhance the degradation effectiveness (Zhang et al. | Low pH level requirement High sludge production Pharmaceuticals may aggregate in the iron sludge created after the treatment (Mahtab et al. Limited H2O2 yield Low unit cell body throughput. Low levels of density and conductivity (M. Zhang et al. |
| Ozonation | Simple, quick, and effective Generation of ozone High elimination rate (Dhodapkar and Gandhi Full mineralization of microcontaminants (Kaur et al. | Short half-life (ozone) No effect on salinity (ozone) (Crini and Lichtfouse |
| Photocatalysis | High degradation percentage (Cheng et al. | Exposure to carcinogenic UV light (Cheng et al. |
Fig. 6Reaction mechanism for the Fenton process (Zhang et al. 2019)
Fig. 7Chemical oxygen demand of CW after treatment by light/Fe0/H2O2 approach with various H2O2/chemical oxygen demand ratios: 0.5:1 (a),1:1 (b), 2:1 (c), and 4:1 (d) and various Fe.0 doses (125–1000 mg/L) (Muszyński et al. 2019)
Cosmetics removal by chemical methods
| Compound | Material | Initial concentration | Removal (%, time) | Major mechanism | Ref |
|---|---|---|---|---|---|
| Methylparaben (MP), ethylparaben (EP), propylparaben (PP), butylparaben (BP) | Ozone | - | 94.85–99.22% of all four simultaneously after 15 min | Ozonation and UV irradiation (O3/UV/TiO2/H2O) | Cuerda-Correa et al. ( |
| Methylparaben (MP), ethylparaben (EP), propylparaben (PP), butylparaben (BP), chemical oxygen demand COD | Ozone | 70 mg H2O2/L, 8 mg O3/L | All parabens 100% after 120 min, COD 70% | O3/H2O2 | Gmurek et al. ( |
| Methylparaben (MP), ethylparaben (EP), propylparaben (PP), butylparaben (BP), chemical oxygen demand COD | TiO2-Pt, TiO2-Pd, TiO2-Ag Ozone | 45 mg O3 | All parabens 100% after 120 min, COD 41–49% | O3/UVA/TiO2-Pt O3/UVA/TiO2-Pd O3/UVA/TiO2-Ag | Gmurek et al. ( |
| Chemical oxygen demand COD | Light/Fe0/H2O2 | 1000 mg/L Fe0 2280 mg/L H2O2 | 70% after 120 min just by the combined process, then 97.7% after SBR | Combined light/Fe0/H2O2 and sequencing batch reactor (SBR) | Muszyński et al. ( |
| Total organic carbon (TOC) | H2O2/Fe3O4/Fe2O3/Fe0 | 500 mg/L Fe3O4 500 mg/L Fe2O3 1000 mg/L Fe0 | 56.2% after 120 min | UV/H2O2/Fe3O4/Fe2O3/Fe0 | Bogacki et al. ( |
| Total organic carbon (TOC), chemical oxygen demand (COD) | Metallurgical waste, H2O2 | MW 8.0 g/L, H2O2 0.05 g/L | TOC 75% after 6 min COD 99% after 6 min | heterogeneous photo Fenton-Like degradation treatment | de Andrade et al. ( |
Brilliant Green Methylene Blue | rGO/Ag2O Nanocomposite | 30 mg in 15 mL MB or BG solution (10 ppm) | BG 75%, after 70 min MB 90%, after 150 min | photocatalytic reduction | Iqbal et al. ( |